A new poll suggests Ontarians are waiting too long for diagnostic tests and specialist appointments, causing unnecessary stress and putting patients’ health at risk. The poll conducted by Abacus Data ...
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...
Collaboration enables patients to access the Octave MSDA test at Quest’s approximately 7,000 patient access sites across the U.S. and establishes a pathway to introduce additional tests from Octave’s ...
YouTube is finally bringing back its direct messaging feature, which has been gone for around six years now, thanks to it being the top requested feature by users who want a messaging experience on ...
We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines: You have to credit our authors. You ...
Artificial intelligence is transforming the everyday practice of medicine — from simplifying diagnostic workflows to helping clinicians make faster, more informed decisions. To explore how AI can ...
For some time now, youtube.com/new has allowed YouTube Premium subscribers to test upcoming features ahead of time before the stable rollout, like more playback speed ...
Earlier this month, YouTube announced several policies and tools to protect users from improper use of artificial intelligence. The proper use of AI, apparently, is doing it through YouTube Labs, “a ...
YouTube on Wednesday will begin testing a new age-verification system in the U.S. that relies on artificial intelligence to differentiate between adults and minors, based on the kinds of videos that ...
The FDA approved the Oncomine Dx Target Test for identifying HER2-mutant NSCLC patients eligible for Hernexeos, an oral tyrosine kinase inhibitor. Hernexeos offers a new treatment option for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results